Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 23 results.
User Information
Export Records
  1. 1.   Cysteine 81 Is Critical for the Interaction of S100A4 and Myosin-IIA
  2. Dulyaninova, N. G.; Hite, K. M.; Zencheck, W. D.; Scudiero, D. A.; Almo, S. C.; Shoemaker, R. H.; Bresnick, A. R.
  3. Biochemistry. 2011, Aug; 50(33): 7218-7227.
  1. 2.   Cdc25A-driven proliferation regulates CD62L levels and lymphocyte movement in response to interleukin-7
  2. Kittipatarin, C.; Li, W. Q.; Durum, S. K.; Khaled, A. R.
  3. Experimental Hematology. 2010, Dec; 38(12): 1143-1156.
  1. 3.   Development of antiproliferative phenylmaleimides that activate the unfolded protein response
  2. Muus, U.; Hose, C.; Yao, W.; Kosakowska-Cholody, T.; Farnsworth, D.; Dyba, M.; Lountos, G. T.; Waugh, D. S.; Monks, A.; Burke, T. R.; Michejda, C. J.
  3. Bioorganic & Medicinal Chemistry. 2010, Jun; 18(12): 4535-4541.
  1. 4.   Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2
  2. Satyanarayana, A.; Berthet, C.; Lopez-Molina, J.; Coppola, V.; Tessarollo, L.; Kaldis, P.
  3. Development. 2008 135(20): 3389-3400.
  1. 5.   p21 inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint
  2. Satyanarayana, A.; Hilton, M. B.; Kaldis, P.
  3. Molecular Biology of the Cell. 2008 19(1): 65-77.
  1. 6.   Detection of in vitro kinase generated protein phosphorylation sites using gamma O-18(4) -ATP and mass Spectrometry
  2. Zhou, M.; Meng, Z.; Jobson, A. G.; Pommier, Y.; Veenstra, T. D.
  3. Analytical Chemistry. 2007, Oct; 79(20): 7603-7610.
  1. 7.   PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo
  2. Kar, S.; Wang, M. F.; Yao, W.; Michejda, C. J.; Carr, B. I.
  3. Molecular Cancer Therapeutics. 2006, Jun; 5(6): 1511-1519.
  1. 8.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 9.   Cell cycling through Cdc25A - Transducer of cytokine proliferative signals
  2. Kittipatarin, C.; Li, W. Q.; Bulavin, D. V.; Durum, S. K.; Khaled, A. R.
  3. Cell Cycle. 2006, May; 5(9): 907-912.
  1. 10.   Cytokinesis regulator ECT2 changes its conformation through phosphorylation at Thr-341 in G2/M phase
  2. Hara, T.; Abe, M.; Inoue, H.; Yu, L. R.; Veenstra, T. D.; Kang, Y. H.; Lee, K. S.; Miki, T.
  3. Oncogene. 2006, JAN; 25(4): 566-578.
  1. 11.   Cell cycle sibling rivalry - Cdc2 vs. Cdk2
  2. Kaldis, P.; Aleem, E.
  3. Cell Cycle. 2005, NOV; 4(11): 1491-1494.
  1. 12.   Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: Implications for cell cycle arrest
  2. Kino, T.; Gragerov, A.; Valentin, A.; Tsopanomihalou, M.; Ilyina-Gragerova, G.; Erwin-Cohen, R.; Chrousos, G. P.; Pavlakis, G. N.
  3. Journal of Virology. 2005, MAR; 79(5): 2780-2787.
  1. 13.   Morphogenesis during Xenopus gastrulation requires Wee1-mediated inhibition of cell proliferation
  2. Murakami, M. S.; Moody, S. A.; Daar, I. O.; Morrison, D. K.
  3. Development. 2004 131(3): 571-580.
  1. 14.   Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate
  2. Muller, J.; Ritt, D. A.; Copeland, T. D.; Morrison, D. K.
  3. Embo Journal. 2003 22(17): 4431-4442.
  1. 15.   C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1
  2. Muller, J.; Ory, S.; Copeland, T. D.; Piwnica-Worms, H.; Morrison, D. K.
  3. Molecular Cell. 2001 8(5): 983-993.
  1. 16.   Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis
  2. Sutterlin, C.; Lin, C. Y.; Feng, Y.; Ferris, D. K.; Erikson, R. L.; Malhotra, V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(16): 9128-9132.
  1. 17.   The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine
  2. Kaldis, P.; Cheng, A. Y.; Solomon, M. J.
  3. Journal of Biological Chemistry. 2000 275(42): 32578-32584.
  1. 18.   UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
  2. Monks, A.; Harris, E. D.; Vaigro-Wolff, A.; Hose, C. D.; Connelly, J. W.; Sausville, E. A.
  3. Investigational New Drugs. 2000 18(2): 95-107.
  1. 19.   RNA-mediated interference of a cdc25 homolog in Caenorhabditis elegans results in defects in the embryonic cortical membrane, meiosis, and mitosis
  2. Ashcroft, N. R.; Srayko, M.; Kosinski, M. E.; Mains, P. E.; Golden, A.
  3. Developmental Biology. 1999 206(1): 15-32.
  1. 20.   A Caenorhabditis elegans wee1 homolog is expressed in a temporally and spatially restricted pattern during embryonic development
  2. Wilson, M. A.; Hoch, R. V.; Ashcroft, N. R.; Kosinski, M. E.; Golden, A.
  3. Biochimica et Biophysica Acta - Gene Structure & Expression. 1999 1445(1): 99-109.
  1. 21.   Anthrax lethal factor causes proteolytic inactivation of mitogen-activated protein kinase kinase
  2. Duesbery, N. S.; Vande Woude, G. F.
  3. Journal of Applied Microbiology. 1999 87(2): 289-293.
  1. 22.   Analysis of the Early Embryonic Cell Cycles of Xenopus - Regulation of Cell Cycle Length By Xe-Wee1 and Mos
  2. Murakami, M. S.; Vande Woude, G. F.
  3. Development. 1998 125(2): 237-248.
  1. 23.   Cell Cycle Regulation of the Human Polo-Like Kinase (Plk) Promoter
  2. Uchiumi, T.; Longo, D. L.; Ferris, D. K.
  3. Journal of Biological Chemistry. 1997 272(14): 9166-9174.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel